Erica Joyner, Author at In The States

About Erica Joyner

This author has not yet filled in any details.
So far Erica Joyner has created 554 blog entries.

Minnesota

The Department of Health (MDH) published the March 2025 list of drugs of substantial public interest with a focus on insulin products. It is the second list published as part of the statutory reporting requirement. You can also find it on MDH’s Public Interest Drug Lists webpage along with the Public Interest List Methodology & Summary—March 2025. Reporting entities, including pharmacies, have approximately 90 days to report (notifications will be sent 30 or more days after the list release date; reports are due 60 days after notifications are sent). Data and analysis from this and other Lists of Drugs of Substantial Public Interest will be made available on the Prescription Drug Price Transparency website. For direct updates, subscribe to the Prescription Drug Price Transparency email list. For more information, visit the Prescription Drug Price Transparency website.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Erica Joyner2025-03-20T15:55:10-04:00March 20, 2025|Minnesota|

Nebraska

Gov. Jim Pillen (R) signed LB 118, legislation increasing the pharmacist-to-pharmacy technician ratio to permit a pharmacist to supervise any combination of pharmacy technicians and pharmacist interns up to four people. For any pharmacist supervising four pharmacy technicians or pharmacist interns, at least one person must be a certified pharmacy technician.

Also in Nebraska, starting on June 1, Medicaid will no longer accept paper applications for Medicaid provider enrollment. All enrollments can be completed electronically at Maximus’ Nebraska Provider Data Management System (PDMS) website. For more information about Maximus’ PDMS, call 844-374-5022 or email at nebraskamedicaidPSE@maximus.com. For questions about how to enroll as a Nebraska Medicaid provider, call 402-471-9018.

Also in Nebraska, on March 19, the Department of Health and Human Services updated provider Bulletin 24-22: Coverage of Interpretation Services.

Finally in Nebraska, the Department of Insurance (NDOI) released a PBM-specific complaint form for reporting concerns. The form is reflective of what is in the Pharmacy Benefit Manager Licensure and Regulation Act that was passed in 2022. There is also a free text space for complaints that do not fall into those statutes. It is important to fill out this form completely and then send it to the NDOI via email or mail as follows:

Email: doi.insurancecomplaints@nebraska.gov

Mail: Nebraska Department of Insurance

P.O. Box 95087

Lincoln, NE 68509-5087

Any materials, medical records or documents that are provided at any time in connection with a complaint will be shared with the insurance companies or PBM against whom the complaint is filed, and their counsel. These documents may also be distributed to other parties engaged in a contested case or other matters pending before the Insurance Commissioner.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

Erica Joyner2025-03-20T15:54:35-04:00March 20, 2025|Nebraska|

Nevada

SB 316, a PBM reform bill that NACDS supports that would require insurers to issue a report to the Insurance Commissioner that includes information regarding prescription cost data to help promote transparency and assess any impact on premiums. The bill also prohibits patient steering to affiliated pharmacies and unfair below cost reimbursements to nonaffiliated pharmacies; ensures any willing pharmacy terms; includes anti-discrimination provisions to protect pharmacy contracting; and subjects PBMs to civil monetary penalties for any violations. The bill is scheduled for a hearing in the Business and Commerce Committee on March 24.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Erica Joyner2025-03-20T15:53:41-04:00March 20, 2025|Nevada|

New York

On March 17, Gov. Kathy Hochul (D) announced the launch of DFS Connect, a new digital program launched by the Department of Financial Services (DFS) that will centralize the Department’s interactions with both regulated entities and consumers and ensure better service to businesses and consumers. Building on the state’s actions to protect New Yorkers from rising drug costs, the initial functions launched today on DFS Connect provide a streamlined and transparent way to file complaints for prescription drug prices that increase more than 50 percent over the course of a year and PBMs. Additionally, individuals can file complaints via mail or by calling the DFS Hotline.

Also in New York, the Office of Health Insurance Programs of the State Department of Health has approved the release of the January 2025 Medicaid Update. Relevant sections are below:

Pharmacy

All Providers

For more information, please contact NACDS’ Mike Sargent at 207-272-6435.

Erica Joyner2025-03-20T15:52:38-04:00March 20, 2025|New York|

Pennsylvania

It is our understanding that the Governor’s office is close to completing its review of the Pharmacy Technician Registration Final Regulation #16A-5433. We anticipate that if the Governor’s office sends the regulations back to IRRC (Independent Regulatory Review Commission) by April 14, IRRC can finalize them at its May 15 meeting. Following that, it would be published in the Pennsylvania Bulletin as final.

Also in Pennsylvania, the PACE Program issued a update regarding manufacturers who, effective April 14, will no longer have their products reimbursed by PACE (Pharmaceutical Assistance Contract for the Elderly).

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Erica Joyner2025-03-20T15:51:39-04:00March 20, 2025|Pennsylvania|

South Dakota

Gov. Larry Rhoden (R) signed SB 154, legislation prohibiting pharmaceutical manufacturers from interfering in contracts between 340B entities and pharmacies and providing a 340B entity or a pharmacy may file a civil action against a pharmaceutical manufacturer for a violation and may request injunctive relief, actual and consequential damages and reasonable attorneys’ fees and costs.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

Erica Joyner2025-03-20T15:50:57-04:00March 20, 2025|South Dakota|

Tennessee

The Emergency Prescription Assistance Program (EPAP) expires April 1. The Tennessee Pharmacists Association (TPA) recently learned that the Administration for Strategic Preparedness and Response (ASPR) does not plan to renew this program beyond the April 1 deadline. Pharmacies are encouraged to use the Healthcare Ready fact sheets to learn how they can best assist their eligible patients while EPAP funding is still available.

Also in Tennessee, TennCare has enhanced reimbursement rates for its Diaper Benefit Program, creating new revenue opportunities for participating pharmacies. Effective February 15, maximum allowable cost (MAC) rates increased for diaper brands on the covered product list, and since February 28, pharmacies have been able to submit claims for private-label and “unlisted” diapers using a Generic Diaper UPC. Diaper program updates provide higher reimbursements, greater inventory flexibility and increased foot traffic for pharmacies statewide.

Finally in Tennessee, the Department of Health is urging clinicians to identify, isolate and inform people regarding suspected measles cases. Immediately report cases by phone at 615-741-7247. According to the CDC (Centers for Disease Control and Prevention), there have been 222 cases of measles across 12 states during 2025 alone, including three identified outbreaks and one pediatric death.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

Erica Joyner2025-03-20T15:50:17-04:00March 20, 2025|Tennessee|

Texas

The highly contagious measles virus continues to spread in the unvaccinated populations in eleven counties. The Department of State Health Services (DSHS) reported that there are currently 279 confirmed measles cases and two deaths since late January.

Also in Texas, March 14 was the bill filing deadline. In total, 5,646 bills have been filed in the House of Representatives and 3,028 in the Senate.

Also in Texas, HB 4051, legislation allowing test-and-treat for certain minor ailments, was filed by Rep. James Frank (R).

Finally in Texas, HB 4533, critical pharmacy legislation that would require a transparent reimbursement methodology for prescription drugs dispensed in Medicaid and state-funded programs, was introduced by Rep. Tom Oliverson, MD, (R).

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Erica Joyner2025-03-20T15:49:07-04:00March 20, 2025|Texas|

Virginia

SB 875 and HB 2610 are now on Gov. Glenn Youngkin’s (R) desk. The bills require the Department of Medical Assistance Services (DMAS) to contract a single PBM to manage the pharmacy benefit under Medicaid Managed Care. Additionally, they would streamline the program and require pass-through pricing and reasonable pharmacy reimbursement. NACDS is currently engaged in both grassroots and grasstops campaigns with members and partners to urge the Governor to sign the bills. The Governor’s deadline to act is midnight on March 24.

Also in Virginia, the Department of Health released a clinician letter outlining requirements for reporting COVID test results.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Erica Joyner2025-03-20T15:48:12-04:00March 20, 2025|Virginia|